Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79:1542–56.
Article CAS PubMed Google Scholar
Younossi ZM, Zelber-Sagi S, Lazarus JV, et al. Global consensus recommendations for metabolic dysfunction-associated steatotic liver disease and steatohepatitis. Gastroenterology. 2025;169:1017–32.
Article CAS PubMed Google Scholar
Targher G, Byrne CD, Tilg H. MASLD: a systemic metabolic disorder with cardiovascular and malignant complications. Gut. 2024;73:691–702.
Article CAS PubMed Google Scholar
European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO). EASL–EASD–EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64:1388–402.
Sterling RK, Duarte-Rojo A, Patel K, et al. AASLD practice guideline on imaging-based noninvasive liver disease assessment of hepatic fibrosis and steatosis. Hepatology. 2025;81:672–724.
Ferraioli G, Barr RG, Berzigotti A, et al. WFUMB guidelines/guidance on liver multiparametric ultrasound. Part 2: guidance on liver fat quantification. Ultrasound Med Biol. 2024;50:1088–98.
Karlas T, Petroff D, Sasso M, et al. Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis. J Hepatol. 2017;66:1022–30.
Petroff D, Blank V, Newsome PN, et al. Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis. Lancet Gastroenterol Hepatol. 2021;6:185–98.
Ferraioli G, Roccarina D, Barr RG. Intersystem and interoperator agreement of US attenuation coefficient for quantifying liver steatosis. Radiology. 2024;313:e240162.
Ferraioli G, Maiocchi L, Raciti MV, et al. Detection of liver steatosis with a novel ultrasound-based technique: a pilot study using MRI-derived proton density fat fraction as the gold standard. Clin Transl Gastroenterol. 2019;10:e00081.
Article PubMed PubMed Central Google Scholar
Burgio MD, Castera L, Oufighou M, et al. Prospective comparison of attenuation imaging and controlled attenuation parameter for liver steatosis diagnosis in patients with nonalcoholic fatty liver disease and type 2 diabetes. Clin Gastroenterol Hepatol. 2024;22:1005-1013.e27.
Nishimura T, Tada T, Akita T, et al. Diagnostic performance of attenuation imaging versus controlled attenuation parameter for hepatic steatosis with MRI-based proton density fat fraction as the reference standard: a prospective multicenter study. J Gastroenterol. 2025;60:727–37.
Article CAS PubMed PubMed Central Google Scholar
Lee DH. Quantitative assessment of fatty liver using ultrasound attenuation imaging. J Med Ultrason. 2021;48:465–70.
Hamaguchi M, Kojima T, Itoh Y, et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol. 2007;102:2708–15.
Ferraioli G, Wong V-WS, Castera L, et al. Liver ultrasound elastography: an update to the world federation for ultrasound in medicine and biology guidelines and recommendations. Ultrasound Med Biol. 2018;44:2419–40.
Ferraioli G, Barr RG, Berzigotti A, et al. WFUMB guideline/guidance on liver multiparametric ultrasound: part 1. Update to 2018 guidelines on liver ultrasound elastography. Ultrasound Med Biol. 2024;50:1071–87.
Tada T, Iijima H, Kobayashi N, et al. Usefulness of attenuation imaging with an ultrasound scanner for the evaluation of hepatic steatosis. Ultrasound Med Biol. 2019;45:2679–87.
Tada T, Kumada T, Gotoh T, et al. Validation of a B-mode ultrasonography scoring system for assessing liver steatosis: a comparison with MRI-derived proton density fat fraction. Hepatol Res. 2025;55:818–29.
Article CAS PubMed Google Scholar
Mukaka MM. Statistics corner: a guide to appropriate use of correlation coefficient in medical research. Malawi Med J. 2012;24:69–71.
CAS PubMed PubMed Central Google Scholar
Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;15:155–63.
Article PubMed PubMed Central Google Scholar
Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307–10.
Article CAS PubMed Google Scholar
DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837–45.
Article CAS PubMed Google Scholar
Hobeika C, Ronot M, Guiu B, et al. Ultrasound-based steatosis grading system using 2D-attenuation imaging: an individual patient data meta-analysis with external validation. Hepatology. 2025;81:212–27.
Choullamy T, Kaadi L, Bezdikian A, et al. Liver fat quantification with ultrasound. Ultrasound Q. 2025;41:e00712.
Ferraioli G, Raimondi A, Maiocchi L, et al. Liver fat quantification with ultrasound: depth dependence of attenuation coefficient. J Ultrasound Med. 2023;42:2247–55.
Sugimoto K, Moriyasu F, Burgio MD, et al. US markers and necroinflammation, steatosis, and fibrosis in metabolic dysfunction–associated steatotic liver disease: the iLEAD study. Radiology. 2024;312:e233377.
Jesper D, Klett D, Schellhaas B, et al. Ultrasound-based attenuation imaging for the non-invasive quantification of liver fat - a pilot study on feasibility and inter-observer variability. IEEE J Transl Eng Health Med. 2020;8:1–9.
Ferraioli G, Maiocchi L, Savietto G, et al. Performance of the attenuation imaging technology in the detection of liver steatosis. J Ultrasound Med. 2021;40:1325–32.
Ferraioli G, Roccarina D, Barr RG. Attenuation coefficient for hepatic steatosis using a single ultrasound system: associations of measurement parameters with interoperator agreement and diagnostic performance. AJR Am J Roentgenol. 2025;224:e2532746.
Ogawa S, Kumada T, Gotoh T, et al. A comparative study of hepatic steatosis using two different qualitative ultrasound techniques measured based on magnetic resonance imaging-derived proton density fat fraction. Hepatol Res. 2024;54:638–54.
Article CAS PubMed Google Scholar
Sugimoto K, Abe M, Oshiro H, et al. The most appropriate region-of-interest position for attenuation coefficient measurement in the evaluation of liver steatosis. J Med Ultrason. 2021;48:615–21.
Bi M, Liu F, Yu J, et al. Preliminary study on determining the optimal position of region of interest for evaluating hepatic steatosis using ultrasound attenuation imaging. Abdom Radiol. 2025;50:4380–8.
Tanaka S, Ohba N, Abe K, et al. The coefficient of determination is affected by the attenuation coefficient in attenuation imaging. Lab Med Int. 2023;2:42–9.
Comments (0)